MNKD Q3 2019 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+226.6% YoY

Gross Profit

$6M38.8% margin

Operating Income

-$9M-60.2% margin

Net Income

-$10M-71.1% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-2.7%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$53M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$95M

Total Liabilities

$280M

Stockholders' Equity

-$185M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$4M	+226.6%
Gross Profit	$6M	-$834,000	+778.7%
Operating Income	-$9M	-$22M	+59.2%
Net Income	-$10M	-$24M	+57.1%

Revenue Segments

Product

$6M100%